NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

Patient and Public Involvement

Home > Welcome > PPIE Case Studies > Patient involvement in research into genetic testing

PPIE Case Studies

PPIE CASE STUDY CATEGORIES

Cancer | Cardiovascular Medicine | Diabetes and Metabolism | Digital Health from Hospital to Home | Genomic Medicine | Haematology and Stem Cells | Imaging | Life-saving Vaccines | Metabolic Experimental Medicine | Musculoskeletal | Obesity, Diet and Lifestyle | Respiratory Medicine | Stroke and Vascular Dementia | ALL

Patient involvement in research into genetic testing

Listed under Genomic Medicine

Background

Oxford’s Genomic Medicine Theme works closely with Headlines, the UK-based charity supporting those with craniosynostosis and other rare craniofacial conditions. This case study shows how the Headlines patient group helped identify research priorities and subsequent research findings.

Around 1 in 2,000 babies are affected by craniosynostosis, a fusion between bones of the skull. The condition causes the skull to grow in a distorted shape, which can lead to serious complications involving vision, hearing, eating and brain function. The NHS Highly Specialised Service in Oxford provides the multidisciplinary assessment and surgery required to correct the alterations in skull shape, treating families from across England.

What we did

The patient representative on the NIHR Cleft and Craniofacial Clinical Studies group and the Headlines patient group identified the Top Ten Questions in Craniosynostosis.

One of the patients’ questions was: “what are the causes of non-syndromic single suture synostosis?”. This question relates to Oxford’s long-standing programme of research, which discovered that a faulty gene or chromosome is responsible for craniosynostosis in around a quarter of children.

What difference did it make

Following identification of this research priority by the Headlines patient group, further research in Oxford discovered mutations in the gene SMAD6 affecting 26 children, 16 of whom had non-syndromic single suture synostosis. This research highlighted the importance of genetics in this type of craniosynostosis.

Articles in the Headlines magazine on SMAD6 and on diagnoses made in the 100,000 Genomes project promoted knowledge of SMAD6 and its implications for patients and families.

From 2021, NHS testing for SMAD6 will be available to all children with non-syndromic single suture midline synostosis, helping to provide an answer for some families to one of Headlines’ Top Ten questions.

Headlines changed their constitution in 2020 to include promotion of research as one of the primary goals of the organisation.

For Patients and the Public

  • Welcome
  • Opportunities for patients and the public
  • Training for patients and the public
  • Public events
Register for the involvement email bulletin
Follow @OxfordPPI
RESEARCHER GUIDANCE →

More Information

  • Patient and public groups
    • Patient and Public Advisory Group
    • Diversity in Research Group
  • Meet the team
  • Case Studies
  • Strategy
  • Videos
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre